MaxCyte, Inc. (LON:MXCT – Get Rating)’s share price was up 3% on Monday . The stock traded as high as GBX 340 ($4.23) and last traded at GBX 340 ($4.23). Approximately 56,453 shares changed hands during mid-day trading, an increase of 86% from the average daily volume of 30,378 shares. The stock had previously closed […]
MaxCyte, Inc. (LON:MXCT – Get Rating) was up 3% during mid-day trading on Monday . The stock traded as high as GBX 340 ($4.23) and last traded at GBX 340 ($4.23). Approximately 56,453 shares changed hands during mid-day trading, an increase of 86% from the average daily volume of 30,378 shares. The stock had previously […]
MaxCyte (NASDAQ:MXCT – Get Rating) and Science 37 (NASDAQ:SNCE – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, valuation, risk, dividends, analyst recommendations and institutional ownership. Analyst Recommendations This is a summary of current recommendations and […]
MaxCyte (NASDAQ:MXCT – Get Rating) and Science 37 (NASDAQ:SNCE – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, risk, analyst recommendations, earnings, institutional ownership, valuation and dividends. Earnings & Valuation This table compares MaxCyte and Science 37’s […]
Gagnon Securities LLC acquired a new stake in MaxCyte, Inc. (NASDAQ:MXCT – Get Rating) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 34,468 shares of the company’s stock, valued at approximately $188,000. Several other hedge funds have also recently bought and sold shares of […]